BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29668082)

  • 1. Altered stress hormone response following acute exercise during prostate cancer treatment.
    Hanson ED; Sakkal S; Evans WS; Violet JA; Battaglini CL; McConell GK; Hayes A
    Scand J Med Sci Sports; 2018 Aug; 28(8):1925-1933. PubMed ID: 29668082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating inflammatory cytokine expression in men with prostate cancer undergoing androgen deprivation therapy.
    Maggio M; Blackford A; Taub D; Carducci M; Ble A; Metter EJ; Braga-Basaria M; Dobs A; Basaria S
    J Androl; 2006; 27(6):725-8. PubMed ID: 16775253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.
    Braga-Basaria M; Dobs AS; Muller DC; Carducci MA; John M; Egan J; Basaria S
    J Clin Oncol; 2006 Aug; 24(24):3979-83. PubMed ID: 16921050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of heat exposure and repeated exercise on circulating stress hormones.
    Brenner IK; Zamecnik J; Shek PN; Shephard RJ
    Eur J Appl Physiol Occup Physiol; 1997; 76(5):445-54. PubMed ID: 9367285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired adrenergic- and corticotropic-axis outflow during exercise in chronic obstructive pulmonary disease.
    Iranmanesh A; Rochester DF; Liu J; Veldhuis JD
    Metabolism; 2011 Nov; 60(11):1521-9. PubMed ID: 21632072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial.
    Uth J; Hornstrup T; Christensen JF; Christensen KB; Jørgensen NR; Schmidt JF; Brasso K; Jakobsen MD; Sundstrup E; Andersen LL; Rørth M; Midtgaard J; Krustrup P; Helge EW
    Osteoporos Int; 2016 Apr; 27(4):1507-1518. PubMed ID: 26572756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.
    Basaria S; Muller DC; Carducci MA; Egan J; Dobs AS
    Cancer; 2006 Feb; 106(3):581-8. PubMed ID: 16388523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell mobilization and egress following acute exercise in men with prostate cancer.
    Hanson ED; Sakkal S; Que S; Cho E; Spielmann G; Kadife E; Violet JA; Battaglini CL; Stoner L; Bartlett DB; McConell GK; Hayes A
    Exp Physiol; 2020 Sep; 105(9):1524-1539. PubMed ID: 32715550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer.
    Ong WL; Foroudi F; Evans S; Millar J
    BJU Int; 2017 Nov; 120 Suppl 3():35-42. PubMed ID: 28749017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced exercise-associated response of the GH-IGF-I axis and catecholamines in obese children and adolescents.
    Eliakim A; Nemet D; Zaldivar F; McMurray RG; Culler FL; Galassetti P; Cooper DM
    J Appl Physiol (1985); 2006 May; 100(5):1630-7. PubMed ID: 16373448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Exercise Adjunct to Radiation and Androgen Deprivation Therapy on Patient-Reported Treatment Toxicity in Men With Prostate Cancer: A Secondary Analysis of 2 Randomized Controlled Trials.
    Schumacher O; Galvão DA; Taaffe DR; Spry N; Joseph D; Tang C; Chee R; Newton RU
    Pract Radiat Oncol; 2021; 11(3):215-225. PubMed ID: 33540038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal Hormone and Metabolic Biomarker Responses to 30 min of Intermittent Cycling Exercise in Breast Cancer Survivors.
    Evans ES; Hackney AC; Pebole MM; McMurray RG; Muss HB; Deal AM; Battaglini CL
    Int J Sports Med; 2016 Nov; 37(12):921-929. PubMed ID: 27490111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
    Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
    Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive decline in prostate cancer patients undergoing ADT: a potential role for exercise training.
    Mundell NL; Daly RM; Macpherson H; Fraser SF
    Endocr Relat Cancer; 2017 Apr; 24(4):R145-R155. PubMed ID: 28209634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial.
    Mottet N; Van Damme J; Loulidi S; Russel C; Leitenberger A; Wolff JM;
    BJU Int; 2012 Nov; 110(9):1262-9. PubMed ID: 22502816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum prostate-specific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy: Tumor malignant potential and androgen milieu.
    Takizawa I; Nishiyama T; Hara N; Isahaya E; Hoshii T; Takahashi K
    Prostate; 2010 Sep; 70(13):1395-401. PubMed ID: 20687212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.
    Hara N; Takizawa I; Isahaya E; Nishiyama T; Hoshii T; Ishizaki F; Takahashi K
    Urol Oncol; 2012 Sep; 30(5):596-601. PubMed ID: 21458314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body image issues and attitudes towards exercise amongst men undergoing androgen deprivation therapy (ADT) following diagnosis of prostate cancer.
    Gentili C; McClean S; Hackshaw-McGeagh L; Bahl A; Persad R; Harcourt D
    Psychooncology; 2019 Aug; 28(8):1647-1653. PubMed ID: 31141623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.